Vimarsana
Biggest News Aggregation in the World

Page 12 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sofinnova Partners Today - Breaking & Trending Today

Mironid extends Series A Funding; £35M Raised To Date - Vimarsana News

Mironid extends Series A Funding; £35M Raised To Date

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Gradient Denervation raises $15M Series A for catheter tech - Vimarsana News

Gradient Denervation raises $15M Series A for catheter tech

Gradient Denervation Technologies announced that it closed a $15 million (€14 million) Series A financing round.

Myricx Enters into Antibody License Agreement with - Vimarsana News

Myricx Enters into Antibody License Agreement with

LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel...

Biocytogen Enters into Antibody Evaluation Option and License Agreement with Myricx for ADC Development - Vimarsana News

Biocytogen Enters into Antibody Evaluation Option and License Agreement with Myricx for ADC Development

Biocytogen Pharmaceuticals a global biotech company focusing on the discovery of novel antibody therapeutics today announces an antibody evaluation option and license agreement with Myricx Bio a UK biotech company focusing on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates ADCs.

iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer - Vimarsana News

iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer

EQS-News: iOmx Therapeutics AG / Key word(s): PersonneliOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer 05.09.2023 / 08:30 CET/CESTThe issuer is solely responsible for the content of this announcement.iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business OfficerMartinsried / Muni...